BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 26277606)

  • 1. The Effectiveness of Pemetrexed Monotherapy Depending on Polymorphisms in TS and MTHFR Genes as Well as Clinical Factors in Advanced NSCLC Patients.
    Kucharczyk T; Krawczyk P; Powrózek T; Kowalski DM; Ramlau R; Kalinka-Warzocha E; Knetki-Wróblewska M; Winiarczyk K; Krzakowski M; Milanowski J
    Pathol Oncol Res; 2016 Jan; 22(1):49-56. PubMed ID: 26277606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of thymidylate synthase predicts clinical outcomes of pemetrexed-containing chemotherapy for non-small-cell lung cancer: a systemic review and meta-analysis.
    Liu Y; Yin TJ; Zhou R; Zhou S; Fan L; Zhang RG
    Cancer Chemother Pharmacol; 2013 Nov; 72(5):1125-32. PubMed ID: 24067998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenetic Analysis of the UK MRC (Medical Research Council) MAGIC Trial: Association of Polymorphisms with Toxicity and Survival in Patients Treated with Perioperative Epirubicin, Cisplatin, and 5-fluorouracil (ECF) Chemotherapy.
    Smyth E; Zhang S; Cunningham D; Wotherspoon A; Soong R; Peckitt C; Valeri N; Fassan M; Rugge M; Okines A; Allum W; Stenning S; Nankivell M; Langley R; Tan P
    Clin Cancer Res; 2017 Dec; 23(24):7543-7549. PubMed ID: 28972045
    [No Abstract]   [Full Text] [Related]  

  • 4. Correlation of toxicities and efficacies of pemetrexed with clinical factors and single-nucleotide polymorphisms: a prospective observational study.
    Takeda Y; Naka G; Katsuya Y; Kobayashi K; Suzuki M; Hashimoto M; Hirano S; Uemura Y
    BMC Cancer; 2023 Aug; 23(1):800. PubMed ID: 37633908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic evaluation of genetic variants in three biological pathways on patient survival in low-stage non-small cell lung cancer.
    Pankratz VS; Sun Z; Aakre J; Li Y; Johnson C; Garces YI; Aubry MC; Molina JR; Wigle DA; Yang P
    J Thorac Oncol; 2011 Sep; 6(9):1488-95. PubMed ID: 21792076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of folate metabolism polymorphisms for lung cancer.
    Matakidou A; El Galta R; Rudd MF; Webb EL; Bridle H; Eisen T; Houlston RS
    Br J Cancer; 2007 Jul; 97(2):247-52. PubMed ID: 17533396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphism in Thymidylate Synthase Gene Predicts Survival and Toxicity in North Indian Lung Cancer Patients Undergoing Platinum-Based Doublet Chemotherapy.
    Sharma P; Singh N; Sharma S
    Oncology; 2022 Jan; ():. PubMed ID: 35086099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SERPINE1 and SERPINB7 as potential biomarkers for intravenous vitamin C treatment in non-small-cell lung cancer.
    Ou J; Liao Q; Du Y; Xi W; Meng Q; Li K; Cai Q; Pang CLK
    Free Radic Biol Med; 2023 Nov; 209(Pt 1):96-107. PubMed ID: 37838303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integration of metabolomics and machine learning revealed tryptophan metabolites are sensitive biomarkers of pemetrexed efficacy in non-small cell lung cancer.
    Sun R; Fei F; Wang M; Jiang J; Yang G; Yang N; Jin D; Xu Z; Cao B; Li J
    Cancer Med; 2023 Sep; 12(18):19245-19259. PubMed ID: 37605514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of single nucleotide polymorphisms of the folylpolyglutamate synthase gene on pemetrexed administration-induced nephropathy.
    Mitarai Y; Tanino R; Nakashima K; Hotta T; Isobe T; Tsubata Y
    Br J Clin Pharmacol; 2023 Dec; 89(12):3551-3560. PubMed ID: 37452621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radio-adaptive response and correlation of non-homologous end joining repair gene polymorphisms [XRRC5 (3R/2R/1R/0R), XRCC6(C/G) and XRCC7 (G/T)] in human peripheral blood mononuclear cells exposed to gamma radiation.
    Shelke S; Das B
    Genes Environ; 2021 Mar; 43(1):9. PubMed ID: 33685509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of CAPN10 gene (rs3842570) polymorphism with the type 2 diabetes mellitus among the population of Noakhali region in Bangladesh: a case-control study.
    Sultana M; Islam MM; Hossain MM; Rahman MA; Das SC; Barman DN; Mitu FS; Gupta SD
    Genomics Inform; 2023 Sep; 21(3):e33. PubMed ID: 37813629
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Sponagel J; Devarakonda S; Rubin JB; Luo J; Ippolito JE
    iScience; 2022 Nov; 25(11):105339. PubMed ID: 36325067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertrophic Pulmonary Osteoarthropathy in Anaplastic Lymphoma Kinase (ALK)-positive Lung Cancer.
    Komatsu M; Yasuo M; Kobayashi N; Tateishi K; Ushiki A; Urushihata K; Yamamoto H; Hanaoka M; Matoba H; Honda T; Ichikawa K
    Intern Med; 2015; 54(16):2045-9. PubMed ID: 26278300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy and safety of panitumumab in the treatment of patients with metastatic colorectal cancer: a meta-analysis from five randomized controlled trials.
    Liang RF; Zheng LL
    Drug Des Devel Ther; 2015; 9():4471-8. PubMed ID: 26300630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrapleural Trastuzumab Therapy for Malignant Pleural Effusion from HER2 Overexpression in Metastatic Gastric Cancer.
    Orlandi E; Mordenti P; Zangrandi A; Cavanna L
    Chemotherapy; 2014; 60(5-6):321-4. PubMed ID: 26279275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Driving ALK Fusion Genes and Genomic Landscape of Medullary Thyroid Cancer.
    Ji JH; Oh YL; Hong M; Yun JW; Lee HW; Kim D; Ji Y; Kim DH; Park WY; Shin HT; Kim KM; Ahn MJ; Park K; Sun JM
    PLoS Genet; 2015 Aug; 11(8):e1005467. PubMed ID: 26295973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer Signature Investigation: ERBB2 (HER2)-Activating Mutation and Amplification-Positive Breast Carcinoma Mimicking Lung Primary.
    Shih J; Bashir B; Gustafson KS; Andrake M; Dunbrack RL; Goldstein LJ; Boumber Y
    J Natl Compr Canc Netw; 2015 Aug; 13(8):947-52. PubMed ID: 26285240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pemetrexed plus platinum versus pemetrexed alone in non-small cell lung cancer patients who have progressed after first-line EGFR TKIs.
    Lee SJ; Sun JM; Lee SH; Ahn JS; Park K; Ahn MJ
    Lung Cancer; 2015 Nov; 90(2):261-6. PubMed ID: 26371700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pemetrexed and interstitial lung disease.
    Adhikari B; Dongol RM; Baral D; Hewett Y; Shah BK
    Acta Oncol; 2016; 55(4):521-2. PubMed ID: 26366501
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.